Hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: risk factors, graft source and survival von Lunde, L E, Dasaraju, S, Cao, Q, Cohn, C S, Reding, M, Bejanyan, N, Trottier, B, Rogosheske, J, Brunstein, C, Warlick, E, Young, J A H, Weisdorf, D J, Ustun, C

Volltext

Lenalidomide Plus Bortezomib (Rev-Vel) in Relapsed and/or Refractory Multiple Myeloma (MM): Final Results of a Multicenter Phase 1 Trial von Richardson, Paul G., Jagannath, S., Avigan, D.E., Alsina, M., Schlossman, R.L., Mazumder, A., Munshi, N.C., Ghobrial, I., Doss, D., McKenney, M.L., Farrell, M.G., Warren, D.L., Lunde, L.E., Gourley, B., Vaccaro, S., Delaney, C., Pountney, S., Mitsiades, C.S., Hideshima, T., Byrne, C., Knight, R., Birner, A., Myers, T., Weller, E., Anderson, K.C.

Volltext

ECAP II-a new electronic circuit analysis program von Branin, F.H., Hogsett, G.R., Lunde, R.L., Kugel, L.E.

Volltext